25+ years biopharmaceutical executive leader and industry innovator
Starting his career as a pharmaceutical process R&D laboratory scientist, Michael K. O’Brien worked his way up to leadership roles in pharmaceutical operations and new technology research, development and commercialization at companies including Wyeth and Pfizer before founding NGT BioPharma Consultants in 2017. His expertise extends to all stages and dimensions of drug development, including API and drug product R&D, technology transfer, regulatory CMC, digital/data technology development, and manufacturing technology innovation.
Michael frequently serves as an invited speaker at international conferences and symposiums. In 2019, he was named an Industry Influencer on The Medicine Maker 2019 Power List.